ManufacturingConfidential

Greenfield Pharmaceutical Plant BIM: Meeting FDA Validation Requirements Through Model-Based QA

Achieving FDA compliance in pharmaceutical manufacturing with BIM-based quality assurance.

Greenfield Pharmaceutical Plant BIM: Meeting FDA Validation Requirements Through Model-Based QA

The Challenge

The creation of a new pharmaceutical manufacturing plant is fraught with complexities, especially when considering the stringent requirements set forth by the FDA. Meeting these exacting standards is crucial to the success and legal operation of any pharmaceutical facility. In a greenfield project, the challenges intensify as processes, workflows, and structures must all harmonise without pre-existing conditions to guide them. For this particular project, the requirement was to ensure that every component of the plant's build adhered to FDA validation processes from inception to execution.

The Solution

Recognising these challenges, Adyantrix initiated a comprehensive BIM strategy with a focus on integrating model-based Quality Assurance (QA) throughout the project's lifecycle. The use of Building Information Modeling (BIM) allowed for a seamless integration of design, execution, and compliance requirements, thereby optimising the project's timelines and reducing potential for errors.

Our team utilised advanced 3D modelling techniques to create a detailed digital representation of the pharmaceutical plant, encompassing everything from structural elements to mechanical, electrical, and plumbing systems. These models were built in accordance with FDA guidelines, allowing stakeholders to visualise compliance at every stage.

A significant component of our strategy was the deployment of clash detection and coordination services. By identifying potential conflicts between various systems early in the design phase, we were able to address issues that could interfere with FDA validation processes and cause costly delays.

Furthermore, our BIM models were instrumental in facilitating a model-based QA process. This innovative approach not only ensured compliance with FDA regulations but also provided a dynamic platform for documenting and managing quality checks throughout construction. By embedding compliance data within the BIM model itself, we enabled ongoing monitoring and rapid adjustments, ensuring that the project stayed on track and fully compliant.

Key Results

The project culminated in the successful construction of a fully compliant pharmaceutical manufacturing plant, meeting all FDA validation requirements. By leveraging BIM-driven QA processes, we helped the client minimize errors and significantly reduce the overall project timeline by 25% compared to industry averages in similar projects.

The integration of a model-based approach also provided the client with enhanced visibility into project stages, enabling better decision-making and proactive issue resolution. This resulted in a smoother handover process, reducing the post-construction modification requirements by 40%.

Ultimately, our BIM solutions not only ensured regulatory compliance but also set a benchmark for efficiency in pharmaceutical plant design and construction, offering a replicable model for future projects in the sector.


← Back to Case Studies

Related Projects

You Might Also Like

0%